Related Experiment Videos
Endothelin-1 decreases postcapillary fluid efflux via prostacyclin release
Gregory P Victorino1, Terry J Chong, Brian Curran
1Department of Surgery, University of California San Francisco-East Bay, Alameda County Medical Center, Oakland, CA 94602, USA.
Surgery
|August 10, 2004
Summary
Prostacyclin (PGI2) reduces endothelial barrier permeability. Inhibiting PGI2 synthesis increases permeability, and endothelin-1 (ET-1) effects are blocked when PGI2 production is inhibited, suggesting PGI2 mediates ET-1's actions.
Area of Science:
- Physiology
- Vascular Biology
- Endocrinology
Background:
- Endothelin-1 (ET-1) is known to decrease endothelial barrier permeability (Lp).
- ET-1's permeability-decreasing effect may be mediated by stimulating prostacyclin (PGI2) release.
- Understanding this interaction is crucial for comprehending microvascular regulation.
Purpose of the Study:
- To investigate the direct effect of PGI2 on Lp.
- To quantify Lp changes following the inhibition of PGI2 synthesis.
- To determine if ET-1's effect on Lp is dependent on PGI2 production.
Main Methods:
- Mesenteric venules were cannulated for Lp measurement.
- PGI2 was infused at varying concentrations (0.1, 1, and 10 µmol/L).
- Lp was assessed after inhibiting PGI2 synthase with tranylcypromine (TCPN) and in combination with ET-1.
Main Results:
- PGI2 significantly decreased Lp at 1 and 10 µmol/L.
- Inhibition of PGI2 synthesis with TCPN markedly increased Lp compared to baseline.
- ET-1's permeability-decreasing effect was abolished when PGI2 synthesis was inhibited.
Conclusions:
- Prostacyclin (PGI2) demonstrably reduces microvessel permeability (Lp).
- Constitutive PGI2 production plays a role in modulating basal microvascular permeability.
- ET-1 likely exerts its permeability-reducing effects through the stimulation of PGI2 release.